OncoGenex to Webcast Update on Clinical Development Program and Discussion of Fourth Quarter and Full Year 2012 Financial Results on Thursday, March 7, 2013 - WMBB News 13 - The Panhandle's News Leader
OncoGenex to Webcast Update on Clinical Development Program and Discussion of Fourth Quarter and Full Year 2012 Financial Results on Thursday, March 7, 2013
Wednesday, May 15 2013 11:45 AM EDT2013-05-15 15:45:20 GMT
While cold and flu season is widely discussed, pneumonia season is quickly gaining the spotlight. One in 20 dies from the lung disease each year, and it's what's going around this week. What is pneumonia? PneumoniaMore >>
While cold and flu season is widely discussed, pneumonia season is quickly gaining the spotlight. One in 20 dies from the lung disease each year, and it's what's going around this week.More >>
Wednesday, May 8 2013 9:06 AM EDT2013-05-08 13:06:30 GMT
We all have our aches in our bellies and backs from time to time, but these pains can also be signs of gallstones. Dr. Hatem Mourad from Coastal Urgent Care and Family Medicine warns that gallstones areMore >>
Dr. Hatem Mourad from Coastal Urgent Care and Family Medicine warns that gallstones are what's going around.More >>
Medical Central is the source for local doctors to advertise their businesses, as well as provide clients and viewers with valuable information on their fields of study.More >>
Jessica Foster is originally from Atlanta, Georgia and has worked at WMBB since 2004. She is excited to bring the news to you each weekday on News13 This Morning. Jessica produces 3 medical segments weekly- What's Going Around, Modern Medicine and Mayo Clinic reports.More >>
Medical Central is the source for local doctors to advertise their businesses, as well as provide clients and viewers with valuable information on their fields of study.More >>
Jessica Foster is originally from Atlanta, Georgia and has worked at WMBB since 2004. She is excited to bring the news to you each weekday on News13 This Morning. Jessica produces 3 medical segments weekly- What's Going Around, Modern Medicine and Mayo Clinic reports.More >>
Information contained on this page is provided by companies via press release distributed through PR Newswire, an independent third-party content provider. PR Newswire, WorldNow and this Station make no warranties or representations in connection therewith.
SOURCE OncoGenex Pharmaceuticals, Inc.
BOTHELL, WA and VANCOUVER, Feb. 28, 2013 /PRNewswire/ - OncoGenex
Pharmaceuticals, Inc. (NASDAQ: OGXI) announced today that the Company's
fourth quarter 2012 financial results will be released on Thursday,
March 7, 2013, and that the Company will host a conference call and
live webcast at 4:30 p.m. ET that afternoon. Management will discuss
the company's financial results and provide an update on the business.
To access the webcast, log on to the Investor Relations page of the
OncoGenex website at www.oncogenex.com. Alternatively, you may access the live conference call by dialing
(877) 606-1416 (U.S. & Canada) or (707) 287-9313 (International). A
webcast replay will be available approximately two hours after the call
and will be archived on www.oncogenex.com for 90 days.
ABOUT ONCOGENEX
OncoGenex is a biopharmaceutical company committed to the development
and commercialization of new therapies that address treatment
resistance in cancer patients. OncoGenex has a diverse oncology
pipeline, with each product candidate having a distinct mechanism of
action and representing a unique opportunity for cancer drug
development. OncoGenex and Teva Pharmaceutical Industries
Ltd. (NYSE: TEVA) have entered a global collaboration and license
agreement to develop and commercialize OncoGenex' lead drug candidate,
custirsen. Custirsen is currently in Phase 3 clinical development as a
treatment in men with metastatic castrate-resistant prostate cancer and
in patients with advanced, unresectable non-small cell lung cancer.
OGX-427 is in Phase 2 clinical development and OGX-225 is currently in
pre-clinical development. More information is available at www.OncoGenex.com.
All content © Copyright 2000 - 2013 WorldNow and WMBB. All Rights Reserved. For more information on this site, please read our Privacy Policy and Terms of Service.
